Back to Journals » OncoTargets and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,810 | Dovepress* | 6,718+ | 877 | 7,595 | |
PubMed Central* | 1,092 | 258 | 1,350 | ||
Totals | 7,810 | 1,135 | 8,945 | ||
*Since 27 November 2018 |
View citations on PubMed Central and Google Scholar